Oncocyte Corp Annual Net Income (Loss) Attributable to Parent in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Oncocyte Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
  • Oncocyte Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$13.5M, a 108% decline year-over-year.
  • Oncocyte Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$43.1M, a 24% increase year-over-year.
  • Oncocyte Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$27.8M, a 61.9% increase from 2022.
  • Oncocyte Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$72.9M, a 13.7% decline from 2021.
  • Oncocyte Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$64.1M, a 114% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$27.8M +$45.1M +61.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 -$72.9M -$8.81M -13.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 -$64.1M -$34.2M -114% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-12
2020 -$29.9M -$7.51M -33.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 -$22.4M -$6.67M -42.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-19
2018 -$15.8M +$3.62M +18.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 -$19.4M -$8.21M -73.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$11.2M -$2.43M -27.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 -$8.74M -$3.75M -75.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 -$4.99M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.